HPV L1 virus-like particles vaccine NBP615
Term · Oncology and biomedicine · MLC-T-ONC-014184
A human papillomavirus (HPV) vaccine composed of purified virus-like particles (VLPs) comprised of major capsid (L1) proteins from HPV subtypes 6, 11, 16 and 18, that can potentially be used for active immunization against HPV types 6, 11, 16 and 18. Upon intramuscular (IM) administration, the HPV L1 VLPs vaccine NBP615 activates the immune system to produce antibodies against the HPV subtypes. This protects against HPV infection and HPV-related cancers.
| Identifier | MLC-T-ONC-014184 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | HPV vaccine NBP615; HPV L1 VLPs vaccine NBP615 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014184",
"term": "HPV L1 virus-like particles vaccine NBP615",
"field": "Oncology and biomedicine",
"definition": "A human papillomavirus (HPV) vaccine composed of purified virus-like particles (VLPs) comprised of major capsid (L1) proteins from HPV subtypes 6, 11, 16 and 18, that can potentially be used for active immunization against HPV types 6, 11, 16 and 18. Upon intramuscular (IM) administration, the HPV L1 VLPs vaccine NBP615 activates the immune system to produce antibodies against the HPV subtypes. This protects against HPV infection and HPV-related cancers.",
"synonyms": [
"HPV vaccine NBP615",
"HPV L1 VLPs vaccine NBP615"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/hpv-l1-virus-like-particles-vaccine-nbp615/"
}
Record 8,655 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.